Come up with a name for your new list and we'll add to it:
Codagenix raised a round of funding on June 01, 2012. Investors include
National Institutes of Health.
Codagenix utilizes a platform technology termed SAVE to construct live-attenuated viral vaccines against multiple targets. All live-attenuated vaccines that are currently used in the clinic were devel…